Latest News Read All News CP-CTNet Newsletter - June 2024 I-SCORE 2024, Partner Highlight, Staff Highlight, DMACC Updates, Research Funding Opportunities, Active and DCP-Approved Studies, Upcoming Events June 18 | CP-CTNet DMACC Website DCP Participation at American Society of Clinical Oncology (ASCO) Annual Meeting, May 31 – June 4, 2024 Consider attending these ASCO sessions to learn about the latest from the DCP symptom science and screening research programs, DCP-funded research from NCORP, and to hear from NCI Director W. Kimryn Rathmell, M.D., Ph.D. May 30 | DCP News An Improved Prostate Cancer Biomarker Test May Help Men Avoid Unnecessary Biopsy Researchers funded by NCI have developed and validated a new prostate cancer urinary biomarker test that can help differentiate who should proceed for biopsy after an elevated prostate-specific antigen (PSA) test from those… April 29 | Cancer Prevention Science Blog Cancer Screening with Multicancer Detection Tests: A Translational Science Review This NCI-authored article examines the benefits and harms of multicancer detection tests. This new generation of cancer screening tests offer the potential for using a noninvasive blood test to reduce cancer-related… April 26 | American Cancer Society Journals Blog Posts All Blog Posts Defining Patient Tolerability to Cancer Treatments Helps Reduce Negative Outcomes For decades, cancer patients have participated in clinical trials of new therapies, and clinicians have assessed and recorded any adverse or toxic reactions to the treatments. Over the years, researchers have standardized… An Improved Prostate Cancer Biomarker Test May Help Men Avoid Unnecessary Biopsy Researchers funded by NCI have developed and validated a new prostate cancer urinary biomarker test that can help differentiate who should proceed for biopsy after an elevated prostate-specific antigen (PSA) test from those… Cancer Pain Research Addressing Multiple Causes, Multiple Managements As improved cancer treatments have led to increased cancer survivorship, cancer survivors are now living longer with chronic pain. NCI is supporting research to address this issue. Research Highlights: Barrett’s Esophagus Translational Research Network (BETRNet) Studies Provide Insights into Prevention and Risk for Esophageal Cancer Findings from two studies aimed at learning more about preventing the type of esophageal cancer with the fastest growing incidence rate have emerged recently from the Barrett’s Esophagus Translational Research Network (BETRNet) as it winds down its collaborative activities. Meetings and Events Review All Our Meetings and Events Exploring Chemoprevention Strategies for Bladder Cancer Interception Date(s): Mon, July 29, 2024: 11:00a.m. ET - Mon, July 29, 2024: 12:00p.m. ET Location: Virtual via Webex Impact of Diet on Mucosal Immunity and Immune-mediated Digestive Diseases Date(s): Wed, August 21, 2024: 8:30a.m. ET - Wed, August 21, 2024: 5:00p.m. ET Thu, August 22, 2024: 9:00a.m. ET - Thu, August 22, 2024: 4:00p.m. ET Location: Hybrid NIAID Conference Center & ZoomGov Microbial Host Defense and Effect on Cancer Initiation and Progression Date(s): Wed, September 11, 2024: 1:00p.m. ET - Wed, September 11, 2024: 2:00p.m. ET Location: Virtual via ZoomGov DCP Updates A timely, informative email with the latest DCP research news, funding announcements and deadlines, training opportunities, and more. Videos and Webinars Cancer prevention videos and webinars related to DCP programs are listed here. Infographics Tap on the desired thumbnail below to view its larger version where you may share the infographic via Twitter and Facebook or download the image by clicking on the appropriate icon: